PolyOne to Acquire Chinese Vinyl Compounding Business

PolyOne Corporation announced today that it has signed a definitive agreement to acquire the assets and operations of Ngai Hing PlastChem Company Ltd. This business is the vinyl compounding subsidiary of Ngai Hing Hong Company Limited (The Stock Exchange of Hong Kong: NHH). The current shareholders of Ngai Hing Hong, which is headquartered in Hong Kong, will retain a 5 percent interest in a new company that PolyOne will establish to conduct vinyl compound business in Asia.

"Positioning PolyOne to capture growth within Asia is one of our core strategies," said Stephen D. Newlin, chairman, president and chief executive officer. "This acquisition will allow us to bring manufacturing for one of our primary businesses, Vinyl Compounds, to China and help to accelerate our business growth there."

Included in the transaction is the transfer of a manufacturing facility in Dongguan, a city in the Guangdong province of South China. This plant will be PolyOne's fourth manufacturing site in China; the others make products for its Engineered Materials, Color and Additives, and Polymer Coating Systems businesses.

"We are pleased to welcome the associates of Ngai Hing PlastChem Company to PolyOne," said Robert Rosenau, senior vice president and general manager, Vinyl Compounds. "We believe the combination of NHPC's people and assets with our current Asian customer base, broad product line, market knowledge and technology will make for a winning opportunity in China."

As part of the agreement, PolyOne will also receive 6 million common shares of Ngai Hing Hong Company Limited. The transaction is expected to close during the first half of 2007, pending completion of Stock Exchange of Hong Kong requirements, approval by governmental authorities and other customary closing conditions. PolyOne anticipates the acquisition being accretive to earnings in the first full year of operation.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.